A-M-W

Controlled drug delivery for superior treatment.

Warngau, Germany · Founded 2008

Headquarters
Warngau
Employees
51–200
Founded
2008
Business Model
B2B
Website
a-m-w.eu

About

AMW GmbH is a specialty pharmaceutical company based in Warngau, Germany, focused on developing and manufacturing biodegradable controlled-release drug delivery systems. Founded in 2008 by Dr. W. Fischer, the company develops value-added medicines including biodegradable implants (goserelin and leuprorelin) approved in over 29 countries, as well as transdermal delivery systems. AMW acts as a 'single source' partner for global pharmaceutical companies seeking innovative sustained-release formulations, with its own research and development center and GMP-compliant manufacturing facilities in Bavaria.

Summary

A-M-W is a Biotech company based in Warngau, Germany, founded in 2008.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

A-M-W on Indexed.vc
<a href="https://indexed.vc/companies/a-m-w"><img src="https://indexed.vc/api/badge/company/a-m-w" alt="A-M-W on Indexed.vc" width="260" height="76" /></a>